Otonomy, Inc.;The Regents of the University of California
发明人:
Jay LICHTER,Andrew M. TRAMMEL,Fabrice PIU,Qiang YE,Michael Christopher SCAIFE,Benedikt VOLLRATH,Sergio G. DURON,Luis A. DELLAMARY,Carl LEBEL,Jeffrey P. HARRIS
申请号：
US16824646
公开号：
US20200230051A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.
